JP2011142913A5 - - Google Patents

Download PDF

Info

Publication number
JP2011142913A5
JP2011142913A5 JP2011021746A JP2011021746A JP2011142913A5 JP 2011142913 A5 JP2011142913 A5 JP 2011142913A5 JP 2011021746 A JP2011021746 A JP 2011021746A JP 2011021746 A JP2011021746 A JP 2011021746A JP 2011142913 A5 JP2011142913 A5 JP 2011142913A5
Authority
JP
Japan
Prior art keywords
seq
polypeptide
amino acid
group
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011021746A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011142913A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2011142913A publication Critical patent/JP2011142913A/ja
Publication of JP2011142913A5 publication Critical patent/JP2011142913A5/ja
Withdrawn legal-status Critical Current

Links

JP2011021746A 2003-10-23 2011-02-03 ウイルス感染に対する抵抗性に関連する遺伝子である、oas1における変異の検出 Withdrawn JP2011142913A (ja)

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
US51388803P 2003-10-23 2003-10-23
US60/513,888 2003-10-23
US54237304P 2004-02-06 2004-02-06
US60/542,373 2004-02-06
US55475804P 2004-03-19 2004-03-19
US60/554,758 2004-03-19
US56052404P 2004-04-08 2004-04-08
US60/560,524 2004-04-08
US57832304P 2004-06-09 2004-06-09
US60/578,323 2004-06-09
US58350304P 2004-06-28 2004-06-28
US60/583,503 2004-06-28
US60524304P 2004-08-26 2004-08-26
US60/605,243 2004-08-26

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2006536883A Division JP2007529199A (ja) 2003-10-23 2004-10-22 ウイルス感染に対する抵抗性に関連する遺伝子である、oas1における変異の検出

Publications (2)

Publication Number Publication Date
JP2011142913A JP2011142913A (ja) 2011-07-28
JP2011142913A5 true JP2011142913A5 (cg-RX-API-DMAC7.html) 2012-05-17

Family

ID=42331514

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2011021746A Withdrawn JP2011142913A (ja) 2003-10-23 2011-02-03 ウイルス感染に対する抵抗性に関連する遺伝子である、oas1における変異の検出
JP2012111782A Pending JP2012183069A (ja) 2003-10-23 2012-05-15 ウイルス感染に対する抵抗性に関連する遺伝子である、oas1における変異の検出
JP2013097618A Pending JP2013208117A (ja) 2003-10-23 2013-05-07 ウイルス感染に対する抵抗性に関連する遺伝子である、oas1における変異の検出

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2012111782A Pending JP2012183069A (ja) 2003-10-23 2012-05-15 ウイルス感染に対する抵抗性に関連する遺伝子である、oas1における変異の検出
JP2013097618A Pending JP2013208117A (ja) 2003-10-23 2013-05-07 ウイルス感染に対する抵抗性に関連する遺伝子である、oas1における変異の検出

Country Status (4)

Country Link
US (1) US20050191649A1 (cg-RX-API-DMAC7.html)
JP (3) JP2011142913A (cg-RX-API-DMAC7.html)
IL (1) IL175089A (cg-RX-API-DMAC7.html)
NZ (3) NZ591879A (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0415771A (pt) 2003-10-23 2006-12-26 Illumigen Biosciences Inc detecção de mutações em um gene associado à resistência a infecção viral, oas1
UA95446C2 (ru) 2005-05-04 2011-08-10 Іллюміджен Байосайєнсіз, Інк. Мутаци в генах oas1
US11439689B2 (en) * 2016-11-14 2022-09-13 Kaohsiung Medical University Method for detecting whether glucose metabolism is abnormal, and prevention and treatment therefor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863873A (en) * 1980-01-14 1989-09-05 Esa, Inc. Method for biological testing and/or developing pharmaceuticals for treatment of disorders
US5266459A (en) * 1992-02-24 1993-11-30 The Scripps Research Institute Gaucher's disease: detection of a new mutation in intron 2 of the glucocerebrosidase gene
US5597709A (en) * 1994-01-27 1997-01-28 Human Genome Sciences, Inc. Human growth hormone splice variants hGHV-2(88) and hGHV-3(53)
US5840565A (en) * 1995-08-22 1998-11-24 The Regents Of The University Of California Methods for enhancing the production of viral vaccines in PKR-deficient cell culture
AU3367799A (en) * 1998-03-30 1999-10-18 Esa Inc. Methodology for predicting and/or diagnosing disease
US20010034023A1 (en) * 1999-04-26 2001-10-25 Stanton Vincent P. Gene sequence variations with utility in determining the treatment of disease, in genes relating to drug processing
US20030165921A1 (en) * 2000-02-03 2003-09-04 Tang Y. Tom Novel nucleic acids and polypeptides
AU2001245619A1 (en) * 2000-03-09 2001-09-17 Chiron Corporation Human genes and gene expression products
AU2002341207A1 (en) * 2001-05-08 2002-11-18 Switch Biotech Ag Use of 2'-5'-oligoadenylate synthetase and/or rnasel or nucleic acids encoding them for diagnosis, prophylaxis or treatment of wound healing
US6818420B2 (en) * 2002-02-27 2004-11-16 Biosource International, Inc. Methods of using FET labeled oligonucleotides that include a 3′-5′ exonuclease resistant quencher domain and compositions for practicing the same
US7354908B2 (en) * 2002-04-30 2008-04-08 University Of South Florida Materials and methods for prevention and treatment of RNA viral diseases
WO2004044124A2 (en) * 2002-05-17 2004-05-27 Baylor College Of Medicine Identification of oligoadenylate synthetase-like genes

Similar Documents

Publication Publication Date Title
CL2019002280A1 (es) Vectores virales, adenovirales y composiciones a base de una secuencia de ornitina transcarbamilasa humana (hotch) modificada genéticamente y su uso en el tratamiento de deficiencia de la otc. (divisional solicitud 201602235)
JP2017532966A5 (cg-RX-API-DMAC7.html)
JP2014533518A5 (cg-RX-API-DMAC7.html)
NZ602897A (en) Raav-guanylate cyclase compositions and methods for treating leber’s congenital amaurosis-1 (lca1)
JP2015096070A5 (cg-RX-API-DMAC7.html)
JP2010516252A5 (cg-RX-API-DMAC7.html)
JP2009525757A5 (cg-RX-API-DMAC7.html)
JP2020517635A5 (cg-RX-API-DMAC7.html)
JP2018138049A5 (cg-RX-API-DMAC7.html)
JP2020022459A5 (cg-RX-API-DMAC7.html)
JP2018537087A5 (cg-RX-API-DMAC7.html)
JP2010222379A5 (cg-RX-API-DMAC7.html)
WO2010086189A3 (en) Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
JP2018510622A5 (cg-RX-API-DMAC7.html)
JP2016187361A5 (cg-RX-API-DMAC7.html)
EP4272765A3 (en) Adeno-associated virus (aav) clade f vector and uses therefor
JP2012082206A5 (cg-RX-API-DMAC7.html)
JP2018528253A5 (cg-RX-API-DMAC7.html)
JP2017537622A5 (cg-RX-API-DMAC7.html)
JP2014503206A5 (cg-RX-API-DMAC7.html)
JP2019530462A5 (cg-RX-API-DMAC7.html)
JP2014012022A5 (cg-RX-API-DMAC7.html)
JP2018531624A5 (cg-RX-API-DMAC7.html)
JP2013507907A5 (cg-RX-API-DMAC7.html)
RU2019144161A (ru) Последовательности нуклеиновых кислот и аминокислотные последовательности аденовирусов человекообразных обезьян, исключая человека, содержащие их векторы и их применения